the venture philanthropy model

VENTURES

CG Ventures helps combine philanthropic contributions and investments with donations to fund and speed up production of cures and treatments for LKB1 (STK11) gene mutation, Peutz Jeghers Syndrome (PJS) and Polyposis for the benefit the many communities impacted. 

THE STRATEGY

The strategies involving an Impact Fund, Contracting and or Program Related Investments (PRI) help with larger funding capacity to accommodate faster performance. Early-stage development can also be supported with these strategies.

SINGLE MISSION SCOPES OF WORK

The narrowly tailored scopes of work (SOWs) are aimed at finding cures and treatments for LKB1 (STK11) gene mutation, PJS and its symptoms which include polyposis. These SOWs are designed to validate treatments (by repurposing FDA approved compounds and otherwise) to stop and shrink polyps and to serve as anti-inflammatory, as well as provide cures and treatments for the LKB1 (STK11) gene mutation that causes PJS and many other diseases. 

RETURN ON INVESTMENTS

Curinggentics non-profit organization's proportional returns are reinvested in the non-profit to further advance new discoveries for the benefit of the affected communities. Curinggenetics non-profit organization will continue to reinvest in scopes of work and or companies for the best interest of and for the care of the affected communities. 

Philanthropic, Angel, Venture and other Investors will likely have great returns and exit opportunities with their investments while having a positive impact on the world.